CDMO News
DCN Dx Expands Services with New Regulatory Affairs Offering
DCN Dx has introduced Regulatory Affairs Services, a new solution aimed at helping in vitro diagnostic (IVD) developers and manufacturers efficiently navigate complex regulatory approval processes. The new offering provides comprehensive support for FDA submissions and international regulatory compliance, enabling clients
17 March 2025